We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-3.68%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$982M
AUM Growth
+$92.9M
Cap. Flow
+$134M
Cap. Flow %
13.65%
Top 10 Hldgs %
4.69%
Holding
1,940
New
653
Increased
414
Reduced
285
Closed
576

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$4.61M
2
DPZ icon
Domino's
DPZ
+$3.96M
3
BRKR icon
Bruker
BRKR
+$3.65M
4
TJX icon
TJX Companies
TJX
+$3.62M
5
SBUX icon
Starbucks
SBUX
+$3.58M

Sector Composition

Rank Sector Weight
1 Healthcare 17.3%
2 Industrials 16.2%
3 Technology 12.7%
4 Financials 11.7%
5 Consumer Discretionary 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLV icon
576
State Street Health Care Select Sector SPDR ETF
XLV
$42.7B
$611K 0.06%
4,796
+1,135
+31% +$150K
DXPE icon
577
DXP Enterprises
DXPE
$2.98B
$610K 0.06%
+20,617
New +$632K
BLMN icon
578
Bloomin' Brands
BLMN
$938M
$609K 0.06%
24,341
-63,527
-72% -$1.64M
KR icon
579
Kroger
KR
$34.8B
$609K 0.06%
15,061
-75,993
-83% -$3.19M
AN icon
580
AutoNation
AN
$6.92B
$607K 0.06%
+4,982
New +$563K
EW icon
581
Edwards Lifesciences
EW
$51.7B
$607K 0.06%
5,362
-1,531
-22% -$175K
SNEX icon
582
StoneX
SNEX
$7.94B
$607K 0.06%
46,610
-5,468
-10% -$70.3K
XLY icon
583
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.2B
$607K 0.06%
6,770
+2,168
+47% +$197K
PLAB icon
584
Photronics
PLAB
$1.93B
$605K 0.06%
44,371
+1,777
+4% +$24.1K
ATNM icon
585
Actinium Pharmaceuticals
ATNM
$25M
$604K 0.06%
68,205
+21,108
+45% +$147K
EPC icon
586
Edgewell Personal Care
EPC
$1.31B
$603K 0.06%
+16,601
New +$682K
FBIO icon
587
Fortress Biotech
FBIO
$88.7M
$603K 0.06%
12,479
+2,342
+23% +$114K
PBYI icon
588
Puma Biotechnology
PBYI
$454M
$603K 0.06%
86,040
+71,155
+478% +$533K
DCO icon
589
Ducommun
DCO
$2.98B
$600K 0.06%
11,922
-5,828
-33% -$306K
ACA icon
590
Arcosa
ACA
$7.11B
$598K 0.06%
+11,927
New +$618K
CMPR icon
591
Cimpress
CMPR
$2.31B
$597K 0.06%
6,872
+1,327
+24% +$130K
SYF icon
592
Synchrony
SYF
$25.6B
$597K 0.06%
+12,217
New +$594K
RNST icon
593
Renasant Corp
RNST
$3.91B
$596K 0.06%
+16,530
New +$590K
TMP icon
594
Tompkins Financial
TMP
$1.42B
$595K 0.06%
+7,358
New +$571K
TX icon
595
Ternium
TX
$10.6B
$594K 0.06%
14,052
-6,998
-33% -$342K
PATK icon
596
Patrick Industries
PATK
$2.85B
$593K 0.06%
+10,677
New +$572K
BCRX icon
597
BioCryst Pharmaceuticals
BCRX
$2.4B
$591K 0.06%
+41,116
New +$648K
SONY icon
598
Sony
SONY
$138B
$591K 0.06%
+26,720
New +$559K
VNO icon
599
Vornado Realty Trust
VNO
$7.38B
$590K 0.06%
+14,034
New +$605K
POSH
600
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
$590K 0.06%
+24,818
New +$795K

Similar funds

GSA Capital Partners's Q3 2021 Portfolio in Review

As of Q3 2021, GSA Capital Partners held 1,940 positions worth $982M, up 10% from $889M the previous quarter. Its ten largest holdings account for 4.7% of the portfolio.

GSA Capital Partners deployed $134M of net new capital in Q3 2021, opening 653 new positions and adding to 414 existing holdings. Its largest new stake was Openlane: 280,405 shares worth $4.6M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Amazon, an estimated $4.61M trimmed.

  • GSA Capital Partners's largest Q3 2021 buy was Openlane: 280,405 shares worth $4.6M.
  • GSA Capital Partners added most to BridgeBio Pharma in Q3 2021, an estimated $4.54M increase.
  • GSA Capital Partners's biggest Q3 2021 reduction was Amazon, cutting an estimated $4.61M.
  • GSA Capital Partners fully exited TJX Companies in Q3 2021, selling an estimated $3.62M.
  • GSA Capital Partners's ten largest holdings make up 4.7% of its $982M portfolio in Q3 2021.
  • GSA Capital Partners opened 653 new positions and closed 576 in Q3 2021.
  • GSA Capital Partners's portfolio value rose 10% quarter-over-quarter to $982M.

Based on GSA Capital Partners's 13F filing for Q3 2021, filed 12 Nov 2021.